1 year return (CAGR)
-55.61%
Lantern Pharma Inc Exchange (NASDAQ, USD)
LTRN
1.70
-0.01 (-0.58%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-27.60%
5 year return (CAGR)
-34.69%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
21.73M
Price/Sales
-
Ent value
26.89M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
309.01%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.71 |
| Daily high | 1.73 |
| Daily low | 1.67 |
| Daily Volume | 128K |
| All-time high | 21.92 |
| 1y analyst estimate | 17.50 |
| Beta | 2.33 |
| EPS (TTM) | -1.50 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| LTRN | S&P500 | |
| Current price drop from All-time high | -92.24% | -2.63% |
| Highest price drop | -94.89% | -56.47% |
| Date of highest drop | 27 Mar 2026 | 9 Mar 2009 |
| Avg drop from high | -67.05% | -10.68% |
| Avg time to new high | 175 days | 12 days |
| Max time to new high | 1381 days | 1805 days |
News
